We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
Cap. Flow
+$2.46B
Cap. Flow %
3.31%
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$141M
2
AAPL icon
Apple
AAPL
+$117M
3
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$96.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
PLD icon
Prologis
PLD
+$47.7M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 14.94%
3 Financials 14.18%
4 Consumer Discretionary 10%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHT
2676
Ashford Hospitality Trust
AHT
$21M
$304K ﹤0.01%
6,793
+126
+2% +$8.12K
HNST icon
2677
The Honest Company
HNST
$586M
$303K ﹤0.01%
100,810
+3,076
+3% +$9.59K
HIPO icon
2678
Hippo Holdings
HIPO
$861M
$302K ﹤0.01%
22,236
+2,057
+10% +$30.9K
SRTA
2679
Strata Critical Medical Inc
SRTA
$512M
$299K ﹤0.01%
83,455
+1,992
+2% +$8.51K
PCB icon
2680
PCB Bancorp
PCB
$391M
$299K ﹤0.01%
16,928
+77
+0.5% +$1.43K
QUAD icon
2681
Quad
QUAD
$525M
$299K ﹤0.01%
73,252
+9,910
+16% +$31.5K
BCOV
2682
DELISTED
Brightcove, Inc.
BCOV
$299K ﹤0.01%
57,084
+1,631
+3% +$9.51K
GRPN icon
2683
Groupon
GRPN
$1.02B
$296K ﹤0.01%
34,461
+1,119
+3% +$8.66K
CDLX icon
2684
Cardlytics
CDLX
$21.5M
$293K ﹤0.01%
5,063
+17
+0.3% +$1.05K
RAD
2685
DELISTED
Rite Aid Corporation
RAD
$293K ﹤0.01%
87,866
+162
+0.2% +$770
GBIO
2686
DELISTED
Generation Bio
GBIO
$292K ﹤0.01%
7,433
+367
+5% +$19.3K
ITIC
2687
Investors Title Co
ITIC
$547M
$292K ﹤0.01%
1,976
+15
+0.8% +$2.18K
CHWY icon
2688
Chewy
CHWY
$9.63B
$290K ﹤0.01%
7,816
-35
-0.4% -$1.36K
DHX icon
2689
DHI Group
DHX
$173M
$289K ﹤0.01%
54,707
+296
+0.5% +$1.64K
CLAR icon
2690
Clarus
CLAR
$143M
$288K ﹤0.01%
36,765
+997
+3% +$9.71K
DHC
2691
Diversified Healthcare Trust
DHC
$2.14B
$287K ﹤0.01%
443,320
-234,598
-35% -$232K
BGFV
2692
DELISTED
Big 5 Sporting Goods
BGFV
$285K ﹤0.01%
32,305
+71
+0.2% +$816
OCUL icon
2693
Ocular Therapeutix
OCUL
$2.02B
$285K ﹤0.01%
101,343
+2,011
+2% +$6.66K
AXTI icon
2694
AXT Inc
AXTI
$5.8B
$284K ﹤0.01%
64,738
+699
+1% +$3.41K
TUP
2695
DELISTED
Tupperware Brands Corporation
TUP
$283K ﹤0.01%
68,287
-67,606
-50% -$362K
EGAN icon
2696
eGain
EGAN
$201M
$282K ﹤0.01%
31,242
+899
+3% +$7.4K
NDLS icon
2697
Noodles & Co
NDLS
$107M
$282K ﹤0.01%
6,425
+249
+4% +$10.9K
TTSH
2698
DELISTED
Tile Shop Holdings
TTSH
$281K ﹤0.01%
64,239
+11,334
+21% +$46.6K
KNTE
2699
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$281K ﹤0.01%
46,045
+272
+0.6% +$2.21K
DZSI
2700
DELISTED
DZS Inc. Common Stock
DZSI
$280K ﹤0.01%
22,043
+459
+2% +$5.83K

Similar funds

RhumbLine Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.

  • RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
  • RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
  • RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
  • RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
  • RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
  • RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.